Research in Ethno-Medicine and Education (REMED)

Sponsor
University of Miami (Other)
Overall Status
Completed
CT.gov ID
NCT05907187
Collaborator
Cigna Foundation (Other)
100
1
1
31
3.2

Study Details

Study Description

Brief Summary

The purpose of this study is to gain information about intravaginal practices, like intravaginal "twalet deba", among Haitian women living in South Florida. Intravaginal "twalet deba" may include douching, cleaning inside the vagina with different kinds of products, or using steam/vapor that enter the vagina. The investigators want to help learn the best way to increase early detection and/or prevention for cervical cancer. The investigators would like to know what plants, herbs, commercial products and medicines are used in these practices, how these products are prepared, applied, why these products are used, and how these products affect the vagina and cervix.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cervical Cancer Prevention Education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Intervention to Promote Cervical Cancer Prevention and Early Detection, and Understand the Role of Plants in HPV. (Research in Ethno-Medicine and Education)
Actual Study Start Date :
Nov 7, 2017
Actual Primary Completion Date :
Nov 21, 2018
Actual Study Completion Date :
Jun 9, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Twalet Deba Group

Participants will receive cervical cancer prevention education, and provide self-administered vaginal or cervical specimens and provide specimens of plants, plant-products or herbs most commonly used in the intravaginal cleansing practice of twalet deba. Total expected participation is about 30 days.

Behavioral: Cervical Cancer Prevention Education
Participants will receive in-person, one-time health education on the importance of cervical cancer screening using a short intervention/educational script; and motivation to encourage women to have human papillomavirus (HPV) screening. Participants will also be informed of the nature and risks of HPV infection, and the importance of seeing a doctor including having a gynecologic exam.

Outcome Measures

Primary Outcome Measures

  1. Plant products used for intravaginal twalet deba. [Up to 30 days]

    Identification of the most commonly used plant products for intravaginal twalet deba as measured by the Research in Ethno-Medicine and Education (REMED) tool.

  2. Methods of using plant products for intravaginal twalet deba. [Up to 30 days]

    Identification of the most commonly used methods of using plant products for intravaginal twalet deba as measured by the Research in Ethno-Medicine and Education (REMED) tool.

  3. Cultural beliefs surrounding the practice of intravaginal twalet deba. [Up to 30 days]

    Identification of the most commonly held cultural beliefs surrounding the practice of intravaginal twalet deba as measured by the Research in Ethno-Medicine and Education (REMED) tool.

  4. Health access for cervical cancer screening as measured by REMED tool [Up to 30 days]

    The REMED tool will collect information regarding early detection and prevention of cervical cancer among underserved communities.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or older

  • Self-identifies as Haitian or Haitian-American

  • Resident of Miami-Dade, Broward or Palm Beach County

  • Currently engages in regular intravaginal cleansing practices that involve more than just water alone

  • No history of hysterectomy

  • Speaks Creole or English

Exclusion Criteria:
  • Are adults unwilling or unable to provide consent

  • Individuals less than 18 years of age

  • Pregnant women

  • Prisoners

Contacts and Locations

Locations

Site City State Country Postal Code
1 Martine Poitevien Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami
  • Cigna Foundation

Investigators

  • Principal Investigator: Erin Kobetz-Kerman, PhD, MPH, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Erin Kobetz-Kerman, PhD, MPH, Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT05907187
Other Study ID Numbers:
  • 20170445
  • NCI-2023-00177
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Erin Kobetz-Kerman, PhD, MPH, Professor, University of Miami
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023